SCOPUS 정보 검색 플랫폼

Volumn 80, Issue 17, 2006, Pages 8745-8762

Antibody responses elicited in Macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: Comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection

(8) Derby, Nina R a,b Kraft, Zane a Kan, Elaine c Crooks, Emma T d Barnett, Susan W c Srivastava, Indresh K c Binley, James M d Stamatatos, Leonidas a,b

a SEATTLE BIOMEDICAL RESEARCH INSTITUTE (United States)

b UNIVERSITY OF WASHINGTON (United States)

c NOVARTIS PHARMA AG (Switzerland)

d TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 140; GLYCOPROTEIN GP 160; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOGENICITY; MACACA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN HUMAN IMMUNODEFICIENCY VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS NEUTRALIZATION; VIRUS STRAIN;

AIDS VACCINES; ANIMALS; ANTIBODIES, VIRAL; GENE PRODUCTS, ENV; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE SERA; IMMUNIZATION; MACACA MULATTA; NEUTRALIZATION TESTS; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MACACA MULATTA;

EID: 33748650781 PISSN: 0022538X EISSN: None Source Type: Journal
DOI: 10.1128/JVI.00956-06 Document Type: Article

Times cited : (73)

References (96)

1
- 0035000679
- The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region
- Barnett, S. W., S. Lu, I. Srivastava, S. Cherpelis, A. Gettie, J. Blanchard, S. Wang, I. Mboudjeka, L. Leung, Y. Lian, A. Fong, C. Buckner, A. Ly, S. Hilt, J. Ulmer, C. T. Wild, J. R. Mascola, and L. Stamatatos. 2001. The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region. J. Virol. 75:5526-5540.
- (2001) J. Virol. , vol.75 , pp. 5526-5540
- Barnett, S.W.¹ Lu, S.² Srivastava, I.³ Cherpelis, S.⁴ Gettie, A.⁵ Blanchard, J.⁶ Wang, S.⁷ Mboudjeka, I.⁸ Leung, L.⁹ Lian, Y.¹⁰ Fong, A.¹¹ Buckner, C.¹² Ly, A.¹³ Hilt, S.¹⁴ Ulmer, J.¹⁵ Wild, C.T.¹⁶ Mascola, J.R.¹⁷ Stamatatos, L.¹⁸

2
- 0032949148
- Comparison of the antibody repertoire generated in healthy volunteers following immunization with a monomeric recombinant gp120 construct derived from a CCR5/CXCR4-using human immunodeficiency virus type 1 isolate with sera from naturally infected individuals
- Beddows, S., S. Lister, R. Cheingsong, C. Bruck, and J. Weber. 1999. Comparison of the antibody repertoire generated in healthy volunteers following immunization with a monomeric recombinant gp120 construct derived from a CCR5/CXCR4-using human immunodeficiency virus type 1 isolate with sera from naturally infected individuals. J. Virol. 73:1740-1745.
- (1999) J. Virol. , vol.73 , pp. 1740-1745
- Beddows, S.¹ Lister, S.² Cheingsong, R.³ Bruck, C.⁴ Weber, J.⁵

3
- 21644445378
- Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1
- Beddows, S., N. Schulke, M. Kirschner, K. Barnes, M. Franti, E. Michael, T. Ketas, R. W. Sanders, P. J. Maddon, W. C. Olson, and J. P. Moore. 2005. Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1. J. Virol. 79:8812-8827.
- (2005) J. Virol. , vol.79 , pp. 8812-8827
- Beddows, S.¹ Schulke, N.² Kirschner, M.³ Barnes, K.⁴ Franti, M.⁵ Michael, E.⁶ Ketas, T.⁷ Sanders, R.W.⁸ Maddon, P.J.⁹ Olson, W.C.¹⁰ Moore, J.P.¹¹

4
- 0033985999
- A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure
- Binley, J. M., R. W. Sanders, B. Clas, N. Schuelke, A. Master, Y. Guo, F. Kajumo, D. J. Anselma, P. J. Maddon, W. C. Olson, and J. P. Moore. 2000. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure. J. Virol. 74:627-643.
- (2000) J. Virol. , vol.74 , pp. 627-643
- Binley, J.M.¹ Sanders, R.W.² Clas, B.³ Schuelke, N.⁴ Master, A.⁵ Guo, Y.⁶ Kajumo, F.⁷ Anselma, D.J.⁸ Maddon, P.J.⁹ Olson, W.C.¹⁰ Moore, J.P.¹¹

5
- 0036184790
- Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins
- Binley, J. M., R. W. Sanders, A. Master, C. S. Cayanan, C. L. Wiley, L. Schiffner, B. Travis, S. Kuhmann, D. R. Burton, S. L. Hu, W. C. Olson, and J. P. Moore. 2002. Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 76:2606-2616.
- (2002) J. Virol. , vol.76 , pp. 2606-2616
- Binley, J.M.¹ Sanders, R.W.² Master, A.³ Cayanan, C.S.⁴ Wiley, C.L.⁵ Schiffner, L.⁶ Travis, B.⁷ Kuhmann, S.⁸ Burton, D.R.⁹ Hu, S.L.¹⁰ Olson, W.C.¹¹ Moore, J.P.¹²

6
- 8644251891
- Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
- Binley, J. M., T. Wrin, B. Korber, M. B. Zwick, M. Wang, C. Chappey, G. Stiegler, R. Kunert, S. Zolla-Pazner, H. Katinger, C. J. Petropoulos, and D. R. Burton. 2004. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J. Virol. 78:13232-13252.
- (2004) J. Virol. , vol.78 , pp. 13232-13252
- Binley, J.M.¹ Wrin, T.² Korber, B.³ Zwick, M.B.⁴ Wang, M.⁵ Chappey, C.⁶ Stiegler, G.⁷ Kunert, R.⁸ Zolla-Pazner, S.⁹ Katinger, H.¹⁰ Petropoulos, C.J.¹¹ Burton, D.R.¹²

7
- 4444342579
- Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d
- Bower, J. F., X. Yang, J. Sodroski, and T. M. Ross. 2004. Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d. J. Virol. 78:4710-4719.
- (2004) J. Virol. , vol.78 , pp. 4710-4719
- Bower, J.F.¹ Yang, X.² Sodroski, J.³ Ross, T.M.⁴

8
- 10744224172
- Priming B cell-mediated anti-HIV envelope responses by vaccination allows for the long-term control of infection in macaques exposed to a R5-tropic SHIV
- Buckner, C., L. G. Gines, C. J. Saunders, L. Vojtech, I. Srivastava, A. Gettie, R. Bohm, J. Blanchard, S. W. Barnett, J. T. Safrit, and L. Stamatatos. 2004. Priming B cell-mediated anti-HIV envelope responses by vaccination allows for the long-term control of infection in macaques exposed to a R5-tropic SHIV. Virology 320:167-180.
- (2004) Virology , vol.320 , pp. 167-180
- Buckner, C.¹ Gines, L.G.² Saunders, C.J.³ Vojtech, L.⁴ Srivastava, I.⁵ Gettie, A.⁶ Bohm, R.⁷ Blanchard, J.⁸ Barnett, S.W.⁹ Safrit, J.T.¹⁰ Stamatatos, L.¹¹

9
- 0027985431
- Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody
- Burton, D. R., J. Pyati, R. Koduri, S. J. Sharp, G. B. Thornton, P. W. Parren, L. S. Sawyer, R. M. Hendry, N. Dunlop, P. L. Nara, M. Lamacchia, E. Garratty, E. R. Stiehm, Y. J. Bryson, Y. Cao, J. P. Moore, D. D. Ho, and C. F. I. Barbas. 1994. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266:1024-1027.
- (1994) Science , vol.266 , pp. 1024-1027
- Burton, D.R.¹ Pyati, J.² Koduri, R.³ Sharp, S.J.⁴ Thornton, G.B.⁵ Parren, P.W.⁶ Sawyer, L.S.⁷ Hendry, R.M.⁸ Dunlop, N.⁹ Nara, P.L.¹⁰ Lamacchia, M.¹¹ Garratty, E.¹² Stiehm, E.R.¹³ Bryson, Y.J.¹⁴ Cao, Y.¹⁵ Moore, J.P.¹⁶ Ho, D.D.¹⁷ Barbas, C.F.I.¹⁸

10
- 0037032903
- Interactions of human antibodies, epitope exposure, antibody binding and neutralization of primary isolate HIV-1 virions
- Cavacini, L. A., M. Duval, J. Robinson, and M. R. Posner. 2002. Interactions of human antibodies, epitope exposure, antibody binding and neutralization of primary isolate HIV-1 virions. AIDS 16:2409-2417.
- (2002) AIDS , vol.16 , pp. 2409-2417
- Cavacini, L.A.¹ Duval, M.² Robinson, J.³ Posner, M.R.⁴

11
- 0032876759
- Minimal incidence of serum antibodies reactive with intact primary isolate virions in human immunodeficiency virus type 1-infected individuals
- Cavacini, L. A., J. E. Peterson, E. Nappi, M. Duval, R. Goldstein, K. Mayer, and M. R. Posner. 1999. Minimal incidence of serum antibodies reactive with intact primary isolate virions in human immunodeficiency virus type 1-infected individuals. J. Virol. 73:9638-9641.
- (1999) J. Virol. , vol.73 , pp. 9638-9641
- Cavacini, L.A.¹ Peterson, J.E.² Nappi, E.³ Duval, M.⁴ Goldstein, R.⁵ Mayer, K.⁶ Posner, M.R.⁷

12
- 0036317971
- Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface
- Center, R. J., R. D. Leapman, J. Lebowitz, L. O. Arthur, P. L. Earl, and B. Moss. 2002. Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface. J. Virol. 76:7863-7867.
- (2002) J. Virol. , vol.76 , pp. 7863-7867
- Center, R.J.¹ Leapman, R.D.² Lebowitz, J.³ Arthur, L.O.⁴ Earl, P.L.⁵ Moss, B.⁶

13
- 0036096976
- Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization
- Chakrabarti, B. K., W. P. Kong, B. Y. Wu, Z. Y. Yang, J. Friborg, X. Ling, S. R. King, D. C. Montefiori, and G. J. Nabel. 2002. Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization. J. Virol. 76:5357-5368.
- (2002) J. Virol. , vol.76 , pp. 5357-5368
- Chakrabarti, B.K.¹ Kong, W.P.² Wu, B.Y.³ Yang, Z.Y.⁴ Friborg, J.⁵ Ling, X.⁶ King, S.R.⁷ Montefiori, D.C.⁸ Nabel, G.J.⁹

14
- 20244366399
- Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate
- Chakrabarti, B. K., X. Ling, Z. Y. Yang, D. C. Montefiori, A. Panet, W. P. Kong, B. Welcher, M. K. Louder, J. R. Mascola, and G. J. Nabel. 2005. Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate. Vaccine 23:3434-3445.
- (2005) Vaccine , vol.23 , pp. 3434-3445
- Chakrabarti, B.K.¹ Ling, X.² Yang, Z.Y.³ Montefiori, D.C.⁴ Panet, A.⁵ Kong, W.P.⁶ Welcher, B.⁷ Louder, M.K.⁸ Mascola, J.R.⁹ Nabel, G.J.¹⁰

15
- 0025866787
- Effect of intron a from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells
- Chapman, B. S., R. M. Thayer, K. A. Vincent, and N. L. Haigwood. 1991. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res. 19:3979-3986.
- (1991) Nucleic Acids Res. , vol.19 , pp. 3979-3986
- Chapman, B.S.¹ Thayer, R.M.² Vincent, K.A.³ Haigwood, N.L.⁴

16
- 13844302894
- Structure of an unliganded simian immunodeficiency virus gp120 core
- Chen, B., E. M. Vogan, H. Gong, J. J. Skehel, D. C. Wiley, and S. C. Harrison. 2005. Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 433:834-841.
- (2005) Nature , vol.433 , pp. 834-841
- Chen, B.¹ Vogan, E.M.² Gong, H.³ Skehel, J.J.⁴ Wiley, D.C.⁵ Harrison, S.C.⁶

17
- 0034703835
- Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein
- Coeffier, E., J. M. Clement, V. Cussac, N. Khodaei-Boorane, M. Jehanno, M. Rojas, A. Dridi, M. Latour, R. El Habib, F. Barre-Sinoussi, M. Hofnung, and C. Leclerc. 2000. Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein. Vaccine 19:684-693.
- (2000) Vaccine , vol.19 , pp. 684-693
- Coeffier, E.¹ Clement, J.M.² Cussac, V.³ Khodaei-Boorane, N.⁴ Jehanno, M.⁵ Rojas, M.⁶ Dridi, A.⁷ Latour, M.⁸ El Habib, R.⁹ Barre-Sinoussi, F.¹⁰ Hofnung, M.¹¹ Leclerc, C.¹²

18
- 0028116653
- Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D
- Conley, A. J., M. K. Gorny, J. A. Kessler II, L. J. Boots, M. Ossorio-Castro, S. Koenig, D. W. Lineberger, E. A. Emini, C. Williams, and S. Zolla-Pazner. 1994. Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D. J. Virol. 68:6994-7000.
- (1994) J. Virol. , vol.68 , pp. 6994-7000
- Conley, A.J.¹ Gorny, M.K.² Kessler II, J.A.³ Boots, L.J.⁴ Ossorio-Castro, M.⁵ Koenig, S.⁶ Lineberger, D.W.⁷ Emini, E.A.⁸ Williams, C.⁹ Zolla-Pazner, S.¹⁰

19
- 33646720281
- Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization
- Crooks, E. T., P. L. Moore, D. Richman, J. Robinson, J. A. Crooks, M. Franti, N. Schulke, and J. M. Binley. 2006. Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization. Hum. Antibodies 14:1-13.
- (2006) Hum. Antibodies , vol.14 , pp. 1-13
- Crooks, E.T.¹ Moore, P.L.² Richman, D.³ Robinson, J.⁴ Crooks, J.A.⁵ Franti, M.⁶ Schulke, N.⁷ Binley, J.M.⁸

20
- 20844448731
- Antigenic conservation and immunogenicity of the HIV coreceptor binding site
- Decker, J. M., F. Bibollet-Ruche, X. Wei, S. Wang, D. N. Levy, W. Wang, E. Delaporte, M. Peeters, C. A. Derdeyn, S. Allen, E. Hunter, M. S. Saag, J. A. Hoxie, B. H. Hahn, P. D. Kwong, J. E. Robinson, and G. M. Shaw. 2005. Antigenic conservation and immunogenicity of the HIV coreceptor binding site. J. Exp. Med. 201:1407-1419.
- (2005) J. Exp. Med. , vol.201 , pp. 1407-1419
- Decker, J.M.¹ Bibollet-Ruche, F.² Wei, X.³ Wang, S.⁴ Levy, D.N.⁵ Wang, W.⁶ Delaporte, E.⁷ Peeters, M.⁸ Derdeyn, C.A.⁹ Allen, S.¹⁰ Hunter, E.¹¹ Saag, M.S.¹² Hoxie, J.A.¹³ Hahn, B.H.¹⁴ Kwong, P.D.¹⁵ Robinson, J.E.¹⁶ Shaw, G.M.¹⁷

21
- 0037370634
- Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system
- Dong, M., P. F. Zhang, F. Glieder, J. Lee, G. Krishnamurthy, T. VanCott, C. Broder, V. R. Polonis, X. F. Yu, Y. Shao, D. Faix, P. Valente, and G. V. Quinnan, Jr. 2003. Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system. J. Virol. 77:3119-3130.
- (2003) J. Virol. , vol.77 , pp. 3119-3130
- Dong, M.¹ Zhang, P.F.² Glieder, F.³ Lee, J.⁴ Krishnamurthy, G.⁵ Vancott, T.⁶ Broder, C.⁷ Polonis, V.R.⁸ Yu, X.F.⁹ Shao, Y.¹⁰ Faix, D.¹¹ Valente, P.¹² Quinnan Jr., G.V.¹³

22
- 23844468382
- Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelope
- Doria-Rose, N. A., G. H. Learn, A. G. Rodrigo, D. C. Nickle, F. Li, M. Mahalanabis, M. T. Hensel, S. McLaughlin, P. F. Edmonson, D. Montefiori, S. W. Barnett, N. L. Haigwood, and J. I. Mullins. 2005. Human immunodeficiency virus type 1 subtype B ancestral envelope protein is functional and elicits neutralizing antibodies in rabbits similar to those elicited by a circulating subtype B envelope. J. Virol. 79:11214-11224.
- (2005) J. Virol. , vol.79 , pp. 11214-11224
- Doria-Rose, N.A.¹ Learn, G.H.² Rodrigo, A.G.³ Nickle, D.C.⁴ Li, F.⁵ Mahalanabis, M.⁶ Hensel, M.T.⁷ McLaughlin, S.⁸ Edmonson, P.F.⁹ Montefiori, D.¹⁰ Barnett, S.W.¹¹ Haigwood, N.L.¹² Mullins, J.I.¹³

23
- 0035168058
- Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140
- Earl, P. L., W. Sugiura, D. C. Montefiori, C. C. Broder, S. A. Lee, C. Wild, J. Lifson, and B. Moss. 2001. Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140. J. Virol. 75:645-653.
- (2001) J. Virol. , vol.75 , pp. 645-653
- Earl, P.L.¹ Sugiura, W.² Montefiori, D.C.³ Broder, C.C.⁴ Lee, S.A.⁵ Wild, C.⁶ Lifson, J.⁷ Moss, B.⁸

24
- 0029812316
- Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus
- Eckhart, L., W. Raffelsberger, B. Ferko, A. Klima, M. Purtscher, H. Katinger, and F. Ruker. 1996. Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus. J. Gen. Virol. 77:2001-2008.
- (1996) J. Gen. Virol. , vol.77 , pp. 2001-2008
- Eckhart, L.¹ Raffelsberger, W.² Ferko, B.³ Klima, A.⁴ Purtscher, M.⁵ Katinger, H.⁶ Ruker, F.⁷

25
- 0031883554
- A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5
- Farzan, M., H. Choe, L. Vaca, K. Martin, Y. Sun, E. Desjardins, N. Ruffing, L. Wu, R. Wyatt, N. Gerard, C. Gerard, and J. Sodroski. 1998. A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5. J. Virol. 72:1160-1164.
- (1998) J. Virol. , vol.72 , pp. 1160-1164
- Farzan, M.¹ Choe, H.² Vaca, L.³ Martin, K.⁴ Sun, Y.⁵ Desjardins, E.⁶ Ruffing, N.⁷ Wu, L.⁸ Wyatt, R.⁹ Gerard, N.¹⁰ Gerard, C.¹¹ Sodroski, J.¹²

26
- 23844451664
- Biochemical and immunogenic characterization of soluble human immunodeficiency virus type 1 envelope glycoprotein trimers expressed by Semliki Forest virus
- Forsell, M. N., Y. Li, M. Sundback, K. Svehla, P. Liljestrom, J. R. Mascola, R. Wyatt, and G. B. Karlsson Hedestam. 2005. Biochemical and immunogenic characterization of soluble human immunodeficiency virus type 1 envelope glycoprotein trimers expressed by Semliki Forest virus. J. Virol. 79:10902-10914.
- (2005) J. Virol. , vol.79 , pp. 10902-10914
- Forsell, M.N.¹ Li, Y.² Sundback, M.³ Svehla, K.⁴ Liljestrom, P.⁵ Mascola, J.R.⁶ Wyatt, R.⁷ Karlsson Hedestam, G.B.⁸

27
- 19944427052
- Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group M consensus envelope glycoprotein
- Gao, F., E. A. Weaver, Z. Lu, Y. Li, H.-X. Liao, B. Ma, S. M. Alam, R. M. Scearce, L. L. Sutherland, J.-S. Yu, J. M. Decker, G. M. Shaw, D. C. Montefiori, B. T. Korber, B. H. Hahn, and B. F. Haynes. 2005. Antigenicity and immunogenicity of a synthetic human immunodeficiency virus type 1 group M consensus envelope glycoprotein. J. Virol. 79:1154-1163.
- (2005) J. Virol. , vol.79 , pp. 1154-1163
- Gao, F.¹ Weaver, E.A.² Lu, Z.³ Li, Y.⁴ Liao, H.-X.⁵ Ma, B.⁶ Alam, S.M.⁷ Scearce, R.M.⁸ Sutherland, L.L.⁹ Yu, J.-S.¹⁰ Decker, J.M.¹¹ Shaw, G.M.¹² Montefiori, D.C.¹³ Korber, B.T.¹⁴ Hahn, B.H.¹⁵ Haynes, B.F.¹⁶

28
- 0031180974
- Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope
- Garrity, R. R., G. Rimmelzwaan, A. Minassian, W. P. Tsai, G. Lin, J. J. de Jong, J. Goudsmit, and P. L. Nara. 1997. Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope. J. Immunol. 159:279-289.
- (1997) J. Immunol. , vol.159 , pp. 279-289
- Garrity, R.R.¹ Rimmelzwaan, G.² Minassian, A.³ Tsai, W.P.⁴ Lin, G.⁵ De Jong, J.J.⁶ Goudsmit, J.⁷ Nara, P.L.⁸

29
- 0026486570
- Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody
- Gorny, M. K., A. J. Conley, S. Karwowska, A. Buchbinder, J. Y. Xu, E. A. Emini, S. Koenig, and S. Zolla-Pazner. 1992. Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody. J. Virol. 66:7538-7542.
- (1992) J. Virol. , vol.66 , pp. 7538-7542
- Gorny, M.K.¹ Conley, A.J.² Karwowska, S.³ Buchbinder, A.⁴ Xu, J.Y.⁵ Emini, E.A.⁶ Koenig, S.⁷ Zolla-Pazner, S.⁸

30
- 10744228558
- The V3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope
- Gorny, M. K., K. Revesz, C. Williams, B. Volsky, M. K. Louder, C. A. Anyangwe, C. Krachmarov, S. C. Kayman, A. Pinter, A. Nadas, P. N. Nyambi, J. R. Mascola, and S. Zolla-Pazner. 2004. The V3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope. J. Virol. 78:2394-2404.
- (2004) J. Virol. , vol.78 , pp. 2394-2404
- Gorny, M.K.¹ Revesz, K.² Williams, C.³ Volsky, B.⁴ Louder, M.K.⁵ Anyangwe, C.A.⁶ Krachmarov, C.⁷ Kayman, S.C.⁸ Pinter, A.⁹ Nadas, A.¹⁰ Nyambi, P.N.¹¹ Mascola, J.R.¹² Zolla-Pazner, S.¹³

31
- 16244419386
- Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles
- Gorny, M. K., L. Stamatatos, B. Volsky, K. Revesz, C. Williams, X. H. Wang, S. Cohen, R. Staudinger, and S. Zolla-Pazner. 2005. Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles. J. Virol. 79:5232-5237.
- (2005) J. Virol. , vol.79 , pp. 5232-5237
- Gorny, M.K.¹ Stamatatos, L.² Volsky, B.³ Revesz, K.⁴ Williams, C.⁵ Wang, X.H.⁶ Cohen, S.⁷ Staudinger, R.⁸ Zolla-Pazner, S.⁹

32
- 0036720793
- Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades
- Gorny, M. K., C. Williams, B. Volsky, K. Revesz, S. Cohen, V. R. Polonis, W. J. Honnen, S. C. Kayman, C. Krachmarov, A. Pinter, and S. Zolla-Pazner. 2002. Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades. J. Virol. 76:9035-9045.
- (2002) J. Virol. , vol.76 , pp. 9035-9045
- Gorny, M.K.¹ Williams, C.² Volsky, B.³ Revesz, K.⁴ Cohen, S.⁵ Polonis, V.R.⁶ Honnen, W.J.⁷ Kayman, S.C.⁸ Krachmarov, C.⁹ Pinter, A.¹⁰ Zolla-Pazner, S.¹¹

33
- 0027311936
- Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120
- Gorny, M. K., J. Y. Xu, S. Karwowska, A. Buchbinder, and S. Zolla-Pazner. 1993. Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120. J. Immunol. 150:635-643.
- (1993) J. Immunol. , vol.150 , pp. 635-643
- Gorny, M.K.¹ Xu, J.Y.² Karwowska, S.³ Buchbinder, A.⁴ Zolla-Pazner, S.⁵

34
- 9944264023
- Analysis of the neutralizing antibody response elicited in rabbits by repeated inoculation with trimeric HIV-1 envelope glycoproteins
- Grundner, C., Y. Li, M. Louder, J. Mascola, X. Yang, J. Sodroski, and R. Wyatt. 2005. Analysis of the neutralizing antibody response elicited in rabbits by repeated inoculation with trimeric HIV-1 envelope glycoproteins. Virology 331:33-46.
- (2005) Virology , vol.331 , pp. 33-46
- Grundner, C.¹ Li, Y.² Louder, M.³ Mascola, J.⁴ Yang, X.⁵ Sodroski, J.⁶ Wyatt, R.⁷

35
- 1242328730
- Effect of partial and complete variable loop deletions of the human immunodeficiency virus type 1 envelope glycoprotein on the breadth of gp160-specific immune responses
- Gzyl, J., E. Bolesta, A. Wierzbicki, D. Kmieciak, T. Naito, M. Honda, K. Komuro, Y. Kaneko, and D. Kozbor. 2004. Effect of partial and complete variable loop deletions of the human immunodeficiency virus type 1 envelope glycoprotein on the breadth of gp160-specific immune responses. Virology 318:493-506.
- (2004) Virology , vol.318 , pp. 493-506
- Gzyl, J.¹ Bolesta, E.² Wierzbicki, A.³ Kmieciak, D.⁴ Naito, T.⁵ Honda, M.⁶ Komuro, K.⁷ Kaneko, Y.⁸ Kozbor, D.⁹

36
- 0025042354
- Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies
- Haigwood, N. L., J. R. Shuster, G. K. Moore, H. Lee, P. V. Skiles, K. W. Higgins, P. J. Barr, C. George-Nascimento, and K. S. Steimer. 1990. Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies. AIDS Res. Hum. Retrovir. 6:855-869.
- (1990) AIDS Res. Hum. Retrovir. , vol.6 , pp. 855-869
- Haigwood, N.L.¹ Shuster, J.R.² Moore, G.K.³ Lee, H.⁴ Skiles, P.V.⁵ Higgins, K.W.⁶ Barr, P.J.⁷ George-Nascimento, C.⁸ Steimer, K.S.⁹

37
- 0036644329
- Efficient isolation of novel human monoclonal antibodies with neutralizing activity against HIV-1 from transgenic mice expressing human Ig loci
- He, Y., W. J. Honnen, C. P. Krachmarov, M. Burkhart, S. C. Kayman, J. Corvalan, and A. Pinter. 2002. Efficient isolation of novel human monoclonal antibodies with neutralizing activity against HIV-1 from transgenic mice expressing human Ig loci. J. Immunol. 169:595-605.
- (2002) J. Immunol. , vol.169 , pp. 595-605
- He, Y.¹ Honnen, W.J.² Krachmarov, C.P.³ Burkhart, M.⁴ Kayman, S.C.⁵ Corvalan, J.⁶ Pinter, A.⁷

38
- 0025950326
- Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody
- Ho, D. D., M. S. Fung, Y. Z. Cao, X. L. Li, C. Sun, T. W. Chang, and N. C. Sun. 1991. Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody. Proc. Natl. Acad. Sci. USA 88:8949-8952.
- (1991) Proc. Natl. Acad. Sci. USA , vol.88 , pp. 8949-8952
- Ho, D.D.¹ Fung, M.S.² Cao, Y.Z.³ Li, X.L.⁴ Sun, C.⁵ Chang, T.W.⁶ Sun, N.C.⁷

39
- 0037081391
- Construction of recombinant targeting immunogens incorporating an HIV-1 neutralizing epitope into sites of differing conformational constraint
- Ho, J., K. S. MacDonald, and B. H. Barber. 2002. Construction of recombinant targeting immunogens incorporating an HIV-1 neutralizing epitope into sites of differing conformational constraint. Vaccine 20:1169-1180.
- (2002) Vaccine , vol.20 , pp. 1169-1180
- Ho, J.¹ MacDonald, K.S.² Barber, B.H.³

40
- 13444280027
- Conformational constraints imposed on a pan-neutralizing HIV-1 antibody epitope result in increased antigenicity but not neutralizing response
- Ho, J., R. A. Uger, M. B. Zwick, M. A. Luscher, B. H. Barber, and K. S. MacDonald. 2005. Conformational constraints imposed on a pan-neutralizing HIV-1 antibody epitope result in increased antigenicity but not neutralizing response. Vaccine 23:1559-1573.
- (2005) Vaccine , vol.23 , pp. 1559-1573
- Ho, J.¹ Uger, R.A.² Zwick, M.B.³ Luscher, M.A.⁴ Barber, B.H.⁵ MacDonald, K.S.⁶

41
- 0034904087
- Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge
- Hofmann-Lehmann, R., J. Vlasak, R. A. Rasmussen, B. A. Smith, T. W. Baba, V. Liska, F. Ferrantelli, D. C. Montefiori, H. M. McClure, D. C. Anderson, B. J. Bernacky, T. A. Rizvi, R. Schmidt, L. R. Hill, M. E. Keeling, H. Katinger, G. Stiegler, L. A. Cavacini, M. R. Posner, T. C. Chou, J. Andersen, and R. M. Ruprecht. 2001. Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge. J. Virol. 75:7470-7480.
- (2001) J. Virol. , vol.75 , pp. 7470-7480
- Hofmann-Lehmann, R.¹ Vlasak, J.² Rasmussen, R.A.³ Smith, B.A.⁴ Baba, T.W.⁵ Liska, V.⁶ Ferrantelli, F.⁷ Montefiori, D.C.⁸ McClure, H.M.⁹ Anderson, D.C.¹⁰ Bernacky, B.J.¹¹ Rizvi, T.A.¹² Schmidt, R.¹³ Hill, L.R.¹⁴ Keeling, M.E.¹⁵ Katinger, H.¹⁶ Stiegler, G.¹⁷ Cavacini, L.A.¹⁸ Posner, M.R.¹⁹ Chou, T.C.²⁰ Andersen, J.²¹ Ruprecht, R.M.²² more..

42
- 0003732734
- Garland Science, New York, N.Y.
- Janeway, C. 2004. Immunobiology: the immune system in health and disease, 6th ed. Garland Science, New York, N.Y.
- (2004) Immunobiology: The Immune System in Health and Disease, 6th Ed.
- Janeway, C.¹

43
- 0037195784
- Enhancement of alpha-helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine design
- Joyce, J. G., W. M. Hurni, M. J. Bogusky, V. M. Garsky, X. Liang, M. P. Citron, R. C. Danzeisen, M. D. Miller, J. W. Shiver, and P. M. Keller. 2002. Enhancement of alpha-helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine design. J. Biol. Chem. 277:45811-45820.
- (2002) J. Biol. Chem. , vol.277 , pp. 45811-45820
- Joyce, J.G.¹ Hurni, W.M.² Bogusky, M.J.³ Garsky, V.M.⁴ Liang, X.⁵ Citron, M.P.⁶ Danzeisen, R.C.⁷ Miller, M.D.⁸ Shiver, J.W.⁹ Keller, P.M.¹⁰

44
- 9944225582
- Modified HIV envelope proteins with enhanced binding to neutralizing monoclonal antibodies
- Kang, S. M., F. S. Quan, C. Huang, L. Guo, L. Ye, C. Yang, and R. W. Compans. 2005. Modified HIV envelope proteins with enhanced binding to neutralizing monoclonal antibodies. Virology 331:20-32.
- (2005) Virology , vol.331 , pp. 20-32
- Kang, S.M.¹ Quan, F.S.² Huang, C.³ Guo, L.⁴ Ye, L.⁵ Yang, C.⁶ Compans, R.W.⁷

45
- 0028097964
- Presentation of native epitopes in the V1/V2 and V3 regions of human immunodeficiency virus type 1 gp120 by fusion glycoproteins containing isolated gp120 domains
- Kayman, S. C., Z. Wu, K. Revesz, H. Chen, R. Kopelman, and A. Pinter. 1994. Presentation of native epitopes in the V1/V2 and V3 regions of human immunodeficiency virus type 1 gp120 by fusion glycoproteins containing isolated gp120 domains. J. Virol. 68:400-410.
- (1994) J. Virol. , vol.68 , pp. 400-410
- Kayman, S.C.¹ Wu, Z.² Revesz, K.³ Chen, H.⁴ Kopelman, R.⁵ Pinter, A.⁶

46
- 13144302861
- Comparison of HIV type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies. AIDS Res
- Kim, M., Z. S. Qiao, D. C. Montefiori, B. F. Haynes, E. L. Reinherz, and H. X. Liao. 2005. Comparison of HIV type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies. AIDS Res. Hum. Retrovir. 21:58-67.
- (2005) Hum. Retrovir. , vol.21 , pp. 58-67
- Kim, M.¹ Qiao, Z.S.² Montefiori, D.C.³ Haynes, B.F.⁴ Reinherz, E.L.⁵ Liao, H.X.⁶

47
- 0037225248
- Immunogenicity and ability of variable loop-deleted human immunodeficiency virus type 1 envelope glycoproteins to elicit neutralizing antibodies
- Kim, Y. B., D. P. Han, C. Cao, and M. W. Cho. 2003. Immunogenicity and ability of variable loop-deleted human immunodeficiency virus type 1 envelope glycoproteins to elicit neutralizing antibodies. Virology 305:124-137.
- (2003) Virology , vol.305 , pp. 124-137
- Kim, Y.B.¹ Han, D.P.² Cao, C.³ Cho, M.W.⁴

48
- 23244434512
- Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
- Li, M., F. Gao, J. R. Mascola, L. Stamatatos, V. R. Polonis, M. Koutsoukos, G. Voss, P. Goepfert, P. Gilbert, K. M. Greene, M. Bilska, D. L. Kothe, J. F. Salazar-Gonzalez, X. Wei, J. M. Decker, B. H. Hahn, and D. C. Montefiori. 2005. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 79:10108-10125.
- (2005) J. Virol. , vol.79 , pp. 10108-10125
- Li, M.¹ Gao, F.² Mascola, J.R.³ Stamatatos, L.⁴ Polonis, V.R.⁵ Koutsoukos, M.⁶ Voss, G.⁷ Goepfert, P.⁸ Gilbert, P.⁹ Greene, K.M.¹⁰ Bilska, M.¹¹ Kothe, D.L.¹² Salazar-Gonzalez, J.F.¹³ Wei, X.¹⁴ Decker, J.M.¹⁵ Hahn, B.H.¹⁶ Montefiori, D.C.¹⁷

49
- 31144451337
- Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants
- Li, Y., K. Svehla, N. L. Mathy, G. Voss, J. R. Mascola, and R. Wyatt. 2006. Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants. J. Virol. 80:1414-1426.
- (2006) J. Virol. , vol.80 , pp. 1414-1426
- Li, Y.¹ Svehla, K.² Mathy, N.L.³ Voss, G.⁴ Mascola, J.R.⁵ Wyatt, R.⁶

50
- 0033575483
- Epitope insertion into variable loops of HIV-1 gp120 as a potential means to improve immunogenicity of viral envelope protein
- Liang, X., S. Munshi, J. Shendure, G. Mark III, M. E. Davies, D. C. Freed, D. C. Montefiori, and J. W. Shiver. 1999. Epitope insertion into variable loops of HIV-1 gp120 as a potential means to improve immunogenicity of viral envelope protein. Vaccine 17:2862-2872.
- (1999) Vaccine , vol.17 , pp. 2862-2872
- Liang, X.¹ Munshi, S.² Shendure, J.³ Mark III, G.⁴ Davies, M.E.⁵ Freed, D.C.⁶ Montefiori, D.C.⁷ Shiver, J.W.⁸

51
- 0345734199
- A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV
- Lorin, C., L. Mollet, F. Delebecque, C. Combredet, B. Hurtrel, P. Chameau, M. Brahic, and F. Tangy. 2004. A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV. J. Virol. 78:146-157.
- (2004) J. Virol. , vol.78 , pp. 146-157
- Lorin, C.¹ Mollet, L.² Delebecque, F.³ Combredet, C.⁴ Hurtrel, B.⁵ Chameau, P.⁶ Brahic, M.⁷ Tangy, F.⁸

52
- 0028834461
- A trimeric structural domain of the HIV-1 transmembrane glycoprotein
- Lu, M., S. C. Blacklow, and P. S. Kim. 1995. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat. Struct. Biol. 2:1075-1082.
- (1995) Nat. Struct. Biol. , vol.2 , pp. 1075-1082
- Lu, M.¹ Blacklow, S.C.² Kim, P.S.³

53
- 0031906852
- Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regions
- Lu, S., R. Wyatt, J. F. Richmond, F. Mustafa, S. Wang, J. Weng, D. C. Montefiori, J. Sodroski, and H. L. Robinson. 1998. Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regions. AIDS Res. Hum. Retrovir. 14:151-155.
- (1998) AIDS Res. Hum. Retrovir. , vol.14 , pp. 151-155
- Lu, S.¹ Wyatt, R.² Richmond, J.F.³ Mustafa, F.⁴ Wang, S.⁵ Weng, J.⁶ Montefiori, D.C.⁷ Sodroski, J.⁸ Robinson, H.L.⁹

54
- 29244434984
- Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment
- Luo, M., F. Yuan, Y. Liu, S. Jiang, X. Song, P. Jiang, X. Yin, M. Ding, and H. Deng. 2006. Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment. Vaccine 24:435-442.
- (2006) Vaccine , vol.24 , pp. 435-442
- Luo, M.¹ Yuan, F.² Liu, Y.³ Jiang, S.⁴ Song, X.⁵ Jiang, P.⁶ Yin, X.⁷ Ding, M.⁸ Deng, H.⁹

55
- 0033942750
- V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies
- Ly, A., and L. Stamatatos. 2000. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies. J. Virol. 74:6769-6776.
- (2000) J. Virol. , vol.74 , pp. 6769-6776
- Ly, A.¹ Stamatatos, L.²

56
- 0032947286
- Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies
- Mascola, J. R., M. G. Lewis, G. Stiegler, D. Harris, T. C. VanCott, D. Hayes, M. K. Louder, C. R. Brown, C. V. Sapan, S. S. Frankel, Y. Lu, M. L. Robb, H. Katinger, and D. L. Birx. 1999. Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J. Virol. 73:4009-4018.
- (1999) J. Virol. , vol.73 , pp. 4009-4018
- Mascola, J.R.¹ Lewis, M.G.² Stiegler, G.³ Harris, D.⁴ Vancott, T.C.⁵ Hayes, D.⁶ Louder, M.K.⁷ Brown, C.R.⁸ Sapan, C.V.⁹ Frankel, S.S.¹⁰ Lu, Y.¹¹ Robb, M.L.¹² Katinger, H.¹³ Birx, D.L.¹⁴

57
- 0033951746
- Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
- Mascola, J. R., G. Stiegler, T. C. VanCott, H. Katinger, C. B. Carpenter, C. E. Hanson, H. Beary, D. Hayes, S. S. Frankel, D. L. Birx, and M. G. Lewis. 2000. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6:207-210.
- (2000) Nat. Med. , vol.6 , pp. 207-210
- Mascola, J.R.¹ Stiegler, G.² Vancott, T.C.³ Katinger, H.⁴ Carpenter, C.B.⁵ Hanson, C.E.⁶ Beary, H.⁷ Hayes, D.⁸ Frankel, S.S.⁹ Birx, D.L.¹⁰ Lewis, M.G.¹¹

58
- 0034904098
- Effect of soluble CD4 on exposure of epitopes on primary, intact, native human immunodeficiency virus type 1 virions of different genetic clades
- Mbah, H. A., S. Burda, M. K. Gorny, C. Williams, K. Revesz, S. Zolla-Pazner, and P. N. Nyambi. 2001. Effect of soluble CD4 on exposure of epitopes on primary, intact, native human immunodeficiency virus type 1 virions of different genetic clades. J. Virol. 75:7785-7788.
- (2001) J. Virol. , vol.75 , pp. 7785-7788
- Mbah, H.A.¹ Burda, S.² Gorny, M.K.³ Williams, C.⁴ Revesz, K.⁵ Zolla-Pazner, S.⁶ Nyambi, P.N.⁷

59
- 18244414668
- Immunogenicity of full length and truncated forms of the human immunodeficiency virus type I envelope glycoprotein. Immunol
- McKeating, J. A., C. Shotton, S. Jeffs, C. Palmer, A. Hammond, J. Lewis, K. Oliver, J. May, and P. Balfe. 1996. Immunogenicity of full length and truncated forms of the human immunodeficiency virus type I envelope glycoprotein. Immunol. Lett. 51:101-105.
- (1996) Lett. , vol.51 , pp. 101-105
- McKeating, J.A.¹ Shotton, C.² Jeffs, S.³ Palmer, C.⁴ Hammond, A.⁵ Lewis, J.⁶ Oliver, K.⁷ May, J.⁸ Balfe, P.⁹

60
- 33144486096
- Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1
- Moore, P. L., E. T. Crooks, L. Porter, P. Zhu, C. S. Cayanan, H. Grise, P. Corcoran, M. B. Zwick, M. Franti, L. Morris, K. H. Roux, D. R. Burton, and J. M. Binley. 2006. Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. J. Virol. 80:2515-2528.
- (2006) J. Virol. , vol.80 , pp. 2515-2528
- Moore, P.L.¹ Crooks, E.T.² Porter, L.³ Zhu, P.⁴ Cayanan, C.S.⁵ Grise, H.⁶ Corcoran, P.⁷ Zwick, M.B.⁸ Franti, M.⁹ Morris, L.¹⁰ Roux, K.H.¹¹ Burton, D.R.¹² Binley, J.M.¹³

61
- 0037076265
- Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes
- Moulard, M., S. K. Phogat, Y. Shu, A. F. Labrijn, X. Xiao, J. M. Binley, M. Y. Zhang, I. A. Sidorov, C. C. Broder, J. Robinson, P. W. Parren, D. R. Burton, and D. S. Dimitrov. 2002. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes. Proc. Natl. Acad. Sci. USA 99:6913-6918.
- (2002) Proc. Natl. Acad. Sci. USA , vol.99 , pp. 6913-6918
- Moulard, M.¹ Phogat, S.K.² Shu, Y.³ Labrijn, A.F.⁴ Xiao, X.⁵ Binley, J.M.⁶ Zhang, M.Y.⁷ Sidorov, I.A.⁸ Broder, C.C.⁹ Robinson, J.¹⁰ Parren, P.W.¹¹ Burton, D.R.¹² Dimitrov, D.S.¹³

62
- 0031710046
- Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: A new strategy for studying the immunologic relatedness of HIV-1
- Nyambi, P. N., M. K. Gorny, L. Bastiani, G. van der Groen, C. Williams, and S. Zolla-Pazner. 1998. Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1. J. Virol. 72:9384-9391.
- (1998) J. Virol. , vol.72 , pp. 9384-9391
- Nyambi, P.N.¹ Gorny, M.K.² Bastiani, L.³ Van Der Groen, G.⁴ Williams, C.⁵ Zolla-Pazner, S.⁶

63
- 0033942757
- Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M
- Nyambi, P. N., H. A. Mbah, S. Burda, C. Williams, M. K. Gorny, A. Nadas, and S. Zolla-Pazner. 2000. Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M. J. Virol. 74:7096-7107.
- (2000) J. Virol. , vol.74 , pp. 7096-7107
- Nyambi, P.N.¹ Mbah, H.A.² Burda, S.³ Williams, C.⁴ Gorny, M.K.⁵ Nadas, A.⁶ Zolla-Pazner, S.⁷

64
- 0033765904
- Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes
- Nyambi, P. N., A. Nadas, H. A. Mbah, S. Burda, C. Williams, M. K. Gorny, and S. Zolla-Pazner. 2000. Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes. J. Virol. 74:10670-10680.
- (2000) J. Virol. , vol.74 , pp. 10670-10680
- Nyambi, P.N.¹ Nadas, A.² Mbah, H.A.³ Burda, S.⁴ Williams, C.⁵ Gorny, M.K.⁶ Zolla-Pazner, S.⁷

65
- 0037213247
- Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120
- Pantophlet, R., E. Ollmann Saphire, P. Poignard, P. W. Parren, I. A. Wilson, and D. R. Burton. 2003. Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120. J. Virol. 77:642-658.
- (2003) J. Virol. , vol.77 , pp. 642-658
- Pantophlet, R.¹ Ollmann Saphire, E.² Poignard, P.³ Parren, P.W.⁴ Wilson, I.A.⁵ Burton, D.R.⁶

66
- 0038414622
- Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design
- Pantophlet, R., I. A. Wilson, and D. R. Burton. 2003. Hyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine design. J. Virol. 77:5889-5901.
- (2003) J. Virol. , vol.77 , pp. 5889-5901
- Pantophlet, R.¹ Wilson, I.A.² Burton, D.R.³

67
- 12444337649
- Improved design of an antigen with enhanced specificity for the broadly HIV-neutralizing antibody b12
- Pantophlet, R., I. A. Wilson, and D. R. Burton. 2004. Improved design of an antigen with enhanced specificity for the broadly HIV-neutralizing antibody b12. Protein Eng. Des. Sel. 17:749-758.
- (2004) Protein Eng. Des. Sel. , vol.17 , pp. 749-758
- Pantophlet, R.¹ Wilson, I.A.² Burton, D.R.³

68
- 0034864776
- Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro
- Parren, P. W., P. A. Marx, A. J. Hessell, A. Luckay, J. Harouse, C. Cheng-Mayer, J. P. Moore, and D. R. Burton. 2001. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J. Virol. 75:8340-8347.
- (2001) J. Virol. , vol.75 , pp. 8340-8347
- Parren, P.W.¹ Marx, P.A.² Hessell, A.J.³ Luckay, A.⁴ Harouse, J.⁵ Cheng-Mayer, C.⁶ Moore, J.P.⁷ Burton, D.R.⁸

69
- 0037213278
- Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies
- Poignard, P., M. Moulard, E. Golez, V. Vivona, M. Franti, S. Venturini, M. Wang, P. W. Parren, and D. R. Burton. 2003. Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies. J. Virol. 77:353-365.
- (2003) J. Virol. , vol.77 , pp. 353-365
- Poignard, P.¹ Moulard, M.² Golez, E.³ Vivona, V.⁴ Franti, M.⁵ Venturini, S.⁶ Wang, M.⁷ Parren, P.W.⁸ Burton, D.R.⁹

70
- 0026001658
- An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection
- Posner, M. R., T. Hideshima, T. Cannon, M. Mukherjee, K. H. Mayer, and R. A. Byrn. 1991. An IgG human monoclonal antibody that reacts with HIV-1/GP120, inhibits virus binding to cells, and neutralizes infection. J. Immunol. 146:4325-4332.
- (1991) J. Immunol. , vol.146 , pp. 4325-4332
- Posner, M.R.¹ Hideshima, T.² Cannon, T.³ Mukherjee, M.⁴ Mayer, K.H.⁵ Byrn, R.A.⁶

71
- 0028291731
- Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1
- Roben, P., J. P. Moore, M. Thali, J. Sodroski, C. F. Barbas III, and D. R. Burton. 1994. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. J. Virol. 68:4821-4828.
- (1994) J. Virol. , vol.68 , pp. 4821-4828
- Roben, P.¹ Moore, J.P.² Thali, M.³ Sodroski, J.⁴ Barbas III, C.F.⁵ Burton, D.R.⁶

72
- 0034063445
- Variable-loop-deleted variants of the human immunodeficiency virus type 1 envelope glycoprotein can be stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits
- Sanders, R. W., L. Schiffner, A. Master, F. Kajumo, Y. Guo, T. Dragic, J. P. Moore, and J. M. Binley. 2000. Variable-loop-deleted variants of the human immunodeficiency virus type 1 envelope glycoprotein can be stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits. J. Virol. 74:5091-5100.
- (2000) J. Virol. , vol.74 , pp. 5091-5100
- Sanders, R.W.¹ Schiffner, L.² Master, A.³ Kajumo, F.⁴ Guo, Y.⁵ Dragic, T.⁶ Moore, J.P.⁷ Binley, J.M.⁸

73
- 0036637385
- The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120
- Sanders, R. W., M. Venturi, L. Schiffner, R. Kalyanaraman, H. Katinger, K. O. Lloyd, P. D. Kwong, and J. P. Moore. 2002. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J. Virol. 76:7293-7305.
- (2002) J. Virol. , vol.76 , pp. 7293-7305
- Sanders, R.W.¹ Venturi, M.² Schiffner, L.³ Kalyanaraman, R.⁴ Katinger, H.⁵ Lloyd, K.O.⁶ Kwong, P.D.⁷ Moore, J.P.⁸

74
- 21644446614
- The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner
- Saunders, C. J., R. A. McCaffrey, I. Zharkikh, Z. Kraft, S. E. Malenbaum, B. Burke, C. Cheng-Mayer, and L. Stamatatos. 2005. The V1, V2, and V3 regions of the human immunodeficiency virus type 1 envelope differentially affect the viral phenotype in an isolate-dependent manner. J. Virol. 79:9069-9080.
- (2005) J. Virol. , vol.79 , pp. 9069-9080
- Saunders, C.J.¹ McCaffrey, R.A.² Zharkikh, I.³ Kraft, Z.⁴ Malenbaum, S.E.⁵ Burke, B.⁶ Cheng-Mayer, C.⁷ Stamatatos, L.⁸

75
- 18244422922
- The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of α1→2 mannose residues on the outer face of gp120
- Scanlan, C. N., R. Pantophlet, M. R. Wormald, E. Ollmann Saphire, R. Stanfield, I. A. Wilson, H. Katinger, R. A. Dwek, P. M. Rudd, and D. R. Burton. 2002. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of α1→2 mannose residues on the outer face of gp120. J. Virol. 76:7306-7321.
- (2002) J. Virol. , vol.76 , pp. 7306-7321
- Scanlan, C.N.¹ Pantophlet, R.² Wormald, M.R.³ Ollmann Saphire, E.⁴ Stanfield, R.⁵ Wilson, I.A.⁶ Katinger, H.⁷ Dwek, R.A.⁸ Rudd, P.M.⁹ Burton, D.R.¹⁰

76
- 0036315133
- Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein
- Schulke, N., M. S. Vesanen, R. W. Sanders, P. Zhu, M. Lu, D. J. Anselma, A. R. Villa, P. W. Parren, J. M. Binley, K. H. Roux, P. J. Maddon, J. P. Moore, and W. C. Olson. 2002. Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein. J. Virol. 76:7760-7776.
- (2002) J. Virol. , vol.76 , pp. 7760-7776
- Schulke, N.¹ Vesanen, M.S.² Sanders, R.W.³ Zhu, P.⁴ Lu, M.⁵ Anselma, D.J.⁶ Villa, A.R.⁷ Parren, P.W.⁸ Binley, J.M.⁹ Roux, K.H.¹⁰ Maddon, P.J.¹¹ Moore, J.P.¹² Olson, W.C.¹³

77
- 25144477447
- Comparing antigenicity and immunogenicity of engineered gp120
- Selvarajah, S., B. Puffer, R. Pantophlet, M. Law, R. W. Doms, and D. R. Burton. 2005. Comparing antigenicity and immunogenicity of engineered gp120. J. Virol. 79:12148-12163.
- (2005) J. Virol. , vol.79 , pp. 12148-12163
- Selvarajah, S.¹ Puffer, B.² Pantophlet, R.³ Law, M.⁴ Doms, R.W.⁵ Burton, D.R.⁶

78
- 0032907674
- Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys
- Shibata, R., T. Igarashi, N. Haigwood, A. Buckler-White, R. Ogert, W. Ross, R. Willey, M. W. Cho, and M. A. Martin. 1999. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nat. Med. 5:204-210.
- (1999) Nat. Med. , vol.5 , pp. 204-210
- Shibata, R.¹ Igarashi, T.² Haigwood, N.³ Buckler-White, A.⁴ Ogert, R.⁵ Ross, W.⁶ Willey, R.⁷ Cho, M.W.⁸ Martin, M.A.⁹

79
- 0141788494
- Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate
- Srivastava, I. K., L. Stamatatos, E. Kan, M. Vajdy, Y. Lian, S. Hilt, L. Martin, C. Vita, P. Zhu, K. H. Roux, L. Vojtech, D. C. Montefiori, J. Donnelly, J. B. Ulmer, and S. W. Barnett. 2003. Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate. J. Virol. 77:11244-11259.
- (2003) J. Virol. , vol.77 , pp. 11244-11259
- Srivastava, I.K.¹ Stamatatos, L.² Kan, E.³ Vajdy, M.⁴ Lian, Y.⁵ Hilt, S.⁶ Martin, L.⁷ Vita, C.⁸ Zhu, P.⁹ Roux, K.H.¹⁰ Vojtech, L.¹¹ Montefiori, D.C.¹² Donnelly, J.¹³ Ulmer, J.B.¹⁴ Barnett, S.W.¹⁵

80
- 0037321708
- Changes in the immunogenic properties of soluble gp140 human immunodeficiency virus envelope constructs upon partial deletion of the second hypervariable region
- Srivastava, I. K., K. VanDorsten, L. Vojtech, S. W. Barnett, and L. Stamatatos. 2003. Changes in the immunogenic properties of soluble gp140 human immunodeficiency virus envelope constructs upon partial deletion of the second hypervariable region. J. Virol. 77:2310-2320.
- (2003) J. Virol. , vol.77 , pp. 2310-2320
- Srivastava, I.K.¹ Vandorsten, K.² Vojtech, L.³ Barnett, S.W.⁴ Stamatatos, L.⁵

81
- 0031666180
- An envelope modification that renders a primary, neutralization-resistant clade B human immunodeficiency virus type 1 isolate highly susceptible to neutralization by sera from other clades
- Stamatatos, L., and C. Cheng-Mayer. 1998. An envelope modification that renders a primary, neutralization-resistant clade B human immunodeficiency virus type 1 isolate highly susceptible to neutralization by sera from other clades. J. Virol. 72:7840-7845.
- (1998) J. Virol. , vol.72 , pp. 7840-7845
- Stamatatos, L.¹ Cheng-Mayer, C.²

82
- 0034235058
- Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptible primary HIV type 1 isolates
- Stamatatos, L., M. Lim, and C. Cheng-Mayer. 2000. Generation and structural analysis of soluble oligomeric gp140 envelope proteins derived from neutralization-resistant and neutralization-susceptible primary HIV type 1 isolates. AIDS Res. Hum. Retrovir. 16:981-994.
- (2000) AIDS Res. Hum. Retrovir. , vol.16 , pp. 981-994
- Stamatatos, L.¹ Lim, M.² Cheng-Mayer, C.³

83
- 0032169683
- Effect of major deletions in the V1 and V2 loops of a macrophage-tropic HIV type 1 isolate on viral envelope structure, cell entry, and replication
- Stamatatos, L., M. Wiskerchen, and C. Cheng-Mayer. 1998. Effect of major deletions in the V1 and V2 loops of a macrophage-tropic HIV type 1 isolate on viral envelope structure, cell entry, and replication. AIDS Res. Hum. Retrovir. 14:1129-1139.
- (1998) AIDS Res. Hum. Retrovir. , vol.14 , pp. 1129-1139
- Stamatatos, L.¹ Wiskerchen, M.² Cheng-Mayer, C.³

84
- 0027204667
- Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody
- Sullivan, N., M. Thall, C. Furman, D. D. Ho, and J. Sodroski. 1993. Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody. J. Virol. 67:3674-3679.
- (1993) J. Virol. , vol.67 , pp. 3674-3679
- Sullivan, N.¹ Thall, M.² Furman, C.³ Ho, D.D.⁴ Sodroski, J.⁵

85
- 0027256814
- Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding
- Thali, M., J. P. Moore, C. Furman, M. Charles, D. D. Ho, J. Robinson, and J. Sodroski. 1993. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67:3978-3988.
- (1993) J. Virol. , vol.67 , pp. 3978-3988
- Thali, M.¹ Moore, J.P.² Furman, C.³ Charles, M.⁴ Ho, D.D.⁵ Robinson, J.⁶ Sodroski, J.⁷

86
- 0026085170
- Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody
- Thali, M., U. Olshevsky, C. Furman, D. Gabuzda, M. Posner, and J. Sodroski. 1991. Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody. J. Virol. 65:6188-6193.
- (1991) J. Virol. , vol.65 , pp. 6188-6193
- Thali, M.¹ Olshevsky, U.² Furman, C.³ Gabuzda, D.⁴ Posner, M.⁵ Sodroski, J.⁶

87
- 26444600181
- Structure of the Fab fragment of F105, a broadly reactive anti-human immunodeficiency virus (HIV) antibody that recognizes the CD4 binding site of HIV type 1 gp120
- Wilkinson, R. A., C. Piscitelli, M. Teintze, L. A. Cavacini, M. R. Posner, and C. M. Lawrence. 2005. Structure of the Fab fragment of F105, a broadly reactive anti-human immunodeficiency virus (HIV) antibody that recognizes the CD4 binding site of HIV type 1 gp120. J. Virol. 79:13060-13069.
- (2005) J. Virol. , vol.79 , pp. 13060-13069
- Wilkinson, R.A.¹ Piscitelli, C.² Teintze, M.³ Cavacini, L.A.⁴ Posner, M.R.⁵ Lawrence, C.M.⁶

88
- 0032546844
- The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens
- Wyatt, R., and J. Sodroski. 1998. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280:1884-1888.
- (1998) Science , vol.280 , pp. 1884-1888
- Wyatt, R.¹ Sodroski, J.²

89
- 0027194743
- Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions
- Wyatt, R., N. Sullivan, M. Thali, H. Repke, D. Ho, J. Robinson, M. Posner, and J. Sodroski. 1993. Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions. J. Virol. 67:4557-4565.
- (1993) J. Virol. , vol.67 , pp. 4557-4565
- Wyatt, R.¹ Sullivan, N.² Thali, M.³ Repke, H.⁴ Ho, D.⁵ Robinson, J.⁶ Posner, M.⁷ Sodroski, J.⁸

90
- 0026055421
- Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies
- Xu, J.-Y., M. K. Gorny, T. Palker, S. Karwowska, and S. Zolla-Pazner. 1991. Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies. J. Virol. 65:4832-4838.
- (1991) J. Virol. , vol.65 , pp. 4832-4838
- Xu, J.-Y.¹ Gorny, M.K.² Palker, T.³ Karwowska, S.⁴ Zolla-Pazner, S.⁵

91
- 33646863044
- Immunization with HIV-1 SF162-derived envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection
- Xu, R., I. K. Srivastava, L. Kuller, I. Zarkikh, Z. Kraft, Z. Fagrouch, N. L. Letvin, J. L. Heeney, S. W. Barnett, and L. Stamatatos. 2006. Immunization with HIV-1 SF162-derived envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection. Virology 349:276-289.
- (2006) Virology , vol.349 , pp. 276-289
- Xu, R.¹ Srivastava, I.K.² Kuller, L.³ Zarkikh, I.⁴ Kraft, Z.⁵ Fagrouch, Z.⁶ Letvin, N.L.⁷ Heeney, J.L.⁸ Barnett, S.W.⁹ Stamatatos, L.¹⁰

92
- 0035155850
- Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers
- Yang, X., R. Wyatt, and J. Sodroski. 2001. Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers. J. Virol. 75:1165-1171.
- (2001) J. Virol. , vol.75 , pp. 1165-1171
- Yang, X.¹ Wyatt, R.² Sodroski, J.³

93
- 1842432386
- Selective modification of variable loops alters tropism and enhances immunogenicity of human immunodeficiency virus type 1 envelope
- Yang, Z. Y., B. K. Chakrabarti, L. Xu, B. Welcher, W. P. Kong, K. Leung, A. Panel, J. R. Mascola, and G. J. Nabel. 2004. Selective modification of variable loops alters tropism and enhances immunogenicity of human immunodeficiency virus type 1 envelope. J. Virol. 78:4029-4036.
- (2004) J. Virol. , vol.78 , pp. 4029-4036
- Yang, Z.Y.¹ Chakrabarti, B.K.² Xu, L.³ Welcher, B.⁴ Kong, W.P.⁵ Leung, K.⁶ Panel, A.⁷ Mascola, J.R.⁸ Nabel, G.J.⁹

94
- 0347364638
- Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions
- Zhu, P., E. Chertova, J. Bess, Jr., J. D. Lifson, L. O. Arthur, J. Liu, K. A. Taylor, and K. H. Roux. 2003. Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions. Proc. Natl. Acad. Sci. USA 100:15812-15817.
- (2003) Proc. Natl. Acad. Sci. USA , vol.100 , pp. 15812-15817
- Zhu, P.¹ Chertova, E.² Bess Jr., J.³ Lifson, J.D.⁴ Arthur, L.O.⁵ Liu, J.⁶ Taylor, K.A.⁷ Roux, K.H.⁸

95
- 0038618737
- A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12
- Zwick, M. B., R. Kelleher, R. Jensen, A. F. Labrijn, M. Wang, G. V. Quinnan, Jr., P. W. Parren, and D. R. Burton. 2003. A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12. J. Virol. 77:6965-6978.
- (2003) J. Virol. , vol.77 , pp. 6965-6978
- Zwick, M.B.¹ Kelleher, R.² Jensen, R.³ Labrijn, A.F.⁴ Wang, M.⁵ Quinnan Jr., G.V.⁶ Parren, P.W.⁷ Burton, D.R.⁸

96
- 0034759882
- Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41
- Zwick, M. B., A. F. Labrijn, M. Wang, C. Spenlehauer, E. O. Saphire, J. M. Binley, J. P. Moore, G. Stiegler, H. Katinger, D. R. Burton, and P. W. Parren. 2001. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J. Virol. 75:10892-10905.
- (2001) J. Virol. , vol.75 , pp. 10892-10905
- Zwick, M.B.¹ Labrijn, A.F.² Wang, M.³ Spenlehauer, C.⁴ Saphire, E.O.⁵ Binley, J.M.⁶ Moore, J.P.⁷ Stiegler, G.⁸ Katinger, H.⁹ Burton, D.R.¹⁰ Parren, P.W.¹¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.